Victoria Taylor, British Heart Foundation, "Bridging the gap between discovery and commercialisation: A charity's perspective" - slides from Journeys of Health-Tech Innovation: Products to Market
Mediterranean Green Tourism Meditour by Mary Mulvey Ceo Ecotourism IrelandASCAME
The Meditour forum will highlight, in this session, successful strategies companies that the companies can use to make their tourism products more sustainable. The creation of greener tourism is happening across the whole breadth of the industry, in travel managed on a municipal level or by corporations themselves; the boarder challenges being successfully met in the overall greening of the sector.
What is a patient registry?
In it’s simplest form, a registry is a list of all patients in a physician’s practice who share some characteristic, such as gender, age group, or disease state. By tracking like characteristics, physicians can better organize patient’s care.
Using Healthcare Data for Research @ The Hyve - Campus Party 2016Kees van Bochove
In this presentation, Kees van Bochove, founder & CEO of The Hyve, a services company in biomedical open source software, presents a number of different types of healthcare data. As an example, he also provides details of a project in which The Hyve participates and which uses that kind of data. Covered are: translational medicine data using tranSMART and cBioPortal, population health data using OMOP and OHDSI, and personal health data processing using open mHealth Shimmer and Apache Kafka.
Victoria Taylor, British Heart Foundation, "Bridging the gap between discovery and commercialisation: A charity's perspective" - slides from Journeys of Health-Tech Innovation: Products to Market
Mediterranean Green Tourism Meditour by Mary Mulvey Ceo Ecotourism IrelandASCAME
The Meditour forum will highlight, in this session, successful strategies companies that the companies can use to make their tourism products more sustainable. The creation of greener tourism is happening across the whole breadth of the industry, in travel managed on a municipal level or by corporations themselves; the boarder challenges being successfully met in the overall greening of the sector.
What is a patient registry?
In it’s simplest form, a registry is a list of all patients in a physician’s practice who share some characteristic, such as gender, age group, or disease state. By tracking like characteristics, physicians can better organize patient’s care.
Using Healthcare Data for Research @ The Hyve - Campus Party 2016Kees van Bochove
In this presentation, Kees van Bochove, founder & CEO of The Hyve, a services company in biomedical open source software, presents a number of different types of healthcare data. As an example, he also provides details of a project in which The Hyve participates and which uses that kind of data. Covered are: translational medicine data using tranSMART and cBioPortal, population health data using OMOP and OHDSI, and personal health data processing using open mHealth Shimmer and Apache Kafka.
operationalizing asthma analytic plan using omop cdm brandtMarion Sills
Secondary use of existing electronic health data from
multiple healthcare organizations requires:
• Harmonization of local data structure with a
common data model.
• Harmonization of local source values with a common
vocabulary
Centralized mapping of local source values allows
standardization across organizations
Data conforming to the OMOP CDM V4 can be used to
operationalize observational CER studies.
Implications for Policy, Delivery, or Practice
Though EHRs all use different backend databases,
they can be harmonized to a CDM for research
purposes. We recommend that the EHR industry
move toward having a standard data model so that
the initial harmonization step is less cumbersome.
Precise Patient Registries: The Foundation for Clinical Research & Population...Health Catalyst
Join Dale Sanders as he shares his experience in developing disease registries, the history of patient registries, and the current design patterns in data engineering to create highly precise registries to support clinical research and population health management.
Topics:
*How the definition of the term “patient registry" has evolved from being associated with a federal- or state-mandated reporting requirement to a hospital or health system’s own population of patients, including device registries, drug registries, and procedure registries.
*Why engaging certain populations via group registries allows them to better understand their conditions and reach out for support from others who share their condition.
*Several untapped benefits of registries for disease and quality management.
*When to utilize patient registries to guide decision-making and drive change, especially at the point of care.
*Which of the critical steps to building a disease registry is most important.
*The keys to winning organizational support in order to implement a successful registry initiative.
*Precise patient registries play a significant role in the management of a broad variety of healthcare processes, including chronic diseases and conditions, as well as clinical research.
Understanding how registries are currently built vs. how they should be built is critical to the future of healthcare outcomes improvement, cost reduction, and translational research.
Usage of open source software for Real World Data Analysis in pharmaceutical ...Kees van Bochove
An upcoming area of interest for biopharmaceutical product development, as well as for public health and healthcare system evaluation, is the study of medical outcomes in so-called 'real world data'. This data can originate from electronic medical records in hospitals, general practitioners, pharmacies, insurance companies and even directly from patients, using forums or mobile health apps.
One of the largest open source initiatives for the standardisation and analysis for this type of data is called OHDSI: Observational Health Data Sciences and Informatics. OHDSI leverages the OMOP data model for observational data, and provides data analysis tools for a broad range of use cases. This talk will focus on a number of examples of the application of the OHDSI tooling for observational research, as well as provide a broader introduction of the topic and the use of open source software in pharmaceutical and healthcare context.
The presenter, Kees van Bochove, is founder and CEO of The Hyve, a company based in Utrecht, The Netherlands and Cambridge, MA, US that provides services around open source software in bioinformatics and translational research, such as OHDSI, tranSMART and cBioPortal.
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017ipposi
Medical students taking the elective course in rare diseases are provided a number of patient perspectives throughout the module. This is what IPPOSI presented in 2017.
PPPI - the involvement of patients or people in the design and development o...ipposi
Dr Jean Saunders, University of Limerick, and IPPOSI Board Member (Science) presents at the 5th World Congress on Advanced Clinical Trials and Clinical Research on public and patient involvement in clinical trials.
We hosted this event during London Tech week showcasing a selection of London’s best in HealthTech. Our partners, tech venture firm Hambro Perks kicked-off the evening with a keynote presentation on starting out in the HealthTech industry, the opportunities and challenges that many founders experience and how support and investment from the right advisors is key to success.
This was followed by an impressive line-up of HealthTech and MedTech start-up lightning pitches.
Find further training and resources on our webpage - https://www.brownejacobson.com/sectors-and-services/sectors/technology/healthtech
DevicePharm is an Irvine, California-based provider of marketing strategy and integrated marketing communications solutions for organizations serving medical professionals and healthcare consumers. As the name suggests, our clients are medical device and pharmaceutical companies along with biotech and life sciences firms ranging from investor-backed startups to established market leaders with over $30 billion in annual revenue.
Because we are focused, we understand the specific and dynamic nature of marketing medical devices, the complexities of research-useヨonly products, and the constant change in AdvaMed, PhRma, and FDA regulations. Our knowledge of these markets provides our clients with the expertise and rapid response required to strengthen their position and exceed their goals.
This distinct focus is what helps us deliver outstanding results for our clients.
The DevicePharm team of marketing, creative, multimedia, and medical professionals provides clients with award-winning professional advertising and direct marketing, practitioner and consumer-focused web and e-media design, comprehensive medical education, and
direct-to-consumer and physician-to-consumer programs. In addition, we have demonstrated success in creating new markets by generating physician and consumer demand for emerging and elective medical procedures.
Medical device, biotech, life sciences, and pharmaceutical marketers turn to our experienced and talented team to help them be more competitive and identify opportunities to achieve success.
operationalizing asthma analytic plan using omop cdm brandtMarion Sills
Secondary use of existing electronic health data from
multiple healthcare organizations requires:
• Harmonization of local data structure with a
common data model.
• Harmonization of local source values with a common
vocabulary
Centralized mapping of local source values allows
standardization across organizations
Data conforming to the OMOP CDM V4 can be used to
operationalize observational CER studies.
Implications for Policy, Delivery, or Practice
Though EHRs all use different backend databases,
they can be harmonized to a CDM for research
purposes. We recommend that the EHR industry
move toward having a standard data model so that
the initial harmonization step is less cumbersome.
Precise Patient Registries: The Foundation for Clinical Research & Population...Health Catalyst
Join Dale Sanders as he shares his experience in developing disease registries, the history of patient registries, and the current design patterns in data engineering to create highly precise registries to support clinical research and population health management.
Topics:
*How the definition of the term “patient registry" has evolved from being associated with a federal- or state-mandated reporting requirement to a hospital or health system’s own population of patients, including device registries, drug registries, and procedure registries.
*Why engaging certain populations via group registries allows them to better understand their conditions and reach out for support from others who share their condition.
*Several untapped benefits of registries for disease and quality management.
*When to utilize patient registries to guide decision-making and drive change, especially at the point of care.
*Which of the critical steps to building a disease registry is most important.
*The keys to winning organizational support in order to implement a successful registry initiative.
*Precise patient registries play a significant role in the management of a broad variety of healthcare processes, including chronic diseases and conditions, as well as clinical research.
Understanding how registries are currently built vs. how they should be built is critical to the future of healthcare outcomes improvement, cost reduction, and translational research.
Usage of open source software for Real World Data Analysis in pharmaceutical ...Kees van Bochove
An upcoming area of interest for biopharmaceutical product development, as well as for public health and healthcare system evaluation, is the study of medical outcomes in so-called 'real world data'. This data can originate from electronic medical records in hospitals, general practitioners, pharmacies, insurance companies and even directly from patients, using forums or mobile health apps.
One of the largest open source initiatives for the standardisation and analysis for this type of data is called OHDSI: Observational Health Data Sciences and Informatics. OHDSI leverages the OMOP data model for observational data, and provides data analysis tools for a broad range of use cases. This talk will focus on a number of examples of the application of the OHDSI tooling for observational research, as well as provide a broader introduction of the topic and the use of open source software in pharmaceutical and healthcare context.
The presenter, Kees van Bochove, is founder and CEO of The Hyve, a company based in Utrecht, The Netherlands and Cambridge, MA, US that provides services around open source software in bioinformatics and translational research, such as OHDSI, tranSMART and cBioPortal.
UCD Rare Disease Module 2017 - Dr Derick Mitchell - March 28th 2017ipposi
Medical students taking the elective course in rare diseases are provided a number of patient perspectives throughout the module. This is what IPPOSI presented in 2017.
PPPI - the involvement of patients or people in the design and development o...ipposi
Dr Jean Saunders, University of Limerick, and IPPOSI Board Member (Science) presents at the 5th World Congress on Advanced Clinical Trials and Clinical Research on public and patient involvement in clinical trials.
We hosted this event during London Tech week showcasing a selection of London’s best in HealthTech. Our partners, tech venture firm Hambro Perks kicked-off the evening with a keynote presentation on starting out in the HealthTech industry, the opportunities and challenges that many founders experience and how support and investment from the right advisors is key to success.
This was followed by an impressive line-up of HealthTech and MedTech start-up lightning pitches.
Find further training and resources on our webpage - https://www.brownejacobson.com/sectors-and-services/sectors/technology/healthtech
DevicePharm is an Irvine, California-based provider of marketing strategy and integrated marketing communications solutions for organizations serving medical professionals and healthcare consumers. As the name suggests, our clients are medical device and pharmaceutical companies along with biotech and life sciences firms ranging from investor-backed startups to established market leaders with over $30 billion in annual revenue.
Because we are focused, we understand the specific and dynamic nature of marketing medical devices, the complexities of research-useヨonly products, and the constant change in AdvaMed, PhRma, and FDA regulations. Our knowledge of these markets provides our clients with the expertise and rapid response required to strengthen their position and exceed their goals.
This distinct focus is what helps us deliver outstanding results for our clients.
The DevicePharm team of marketing, creative, multimedia, and medical professionals provides clients with award-winning professional advertising and direct marketing, practitioner and consumer-focused web and e-media design, comprehensive medical education, and
direct-to-consumer and physician-to-consumer programs. In addition, we have demonstrated success in creating new markets by generating physician and consumer demand for emerging and elective medical procedures.
Medical device, biotech, life sciences, and pharmaceutical marketers turn to our experienced and talented team to help them be more competitive and identify opportunities to achieve success.
A Corporate Journey into Digital Education - Mark Priddle and Shirley Fung, P...Blackboard APAC
As one of Australia’s largest providers of GP services, Primary Health Care (PHC) is seeking to play an increased role supporting the education of medical students, GP trainees, and health care professionals. This process was tasked to the Primary Health Care Institute (PHCI). The Institute is responsible for coordinating and delivering education and training to over 1000 doctors, trainees and professional staff nationally. To facilitate this task, the Institute purchased Moodlerooms to implements its delivery of blended education.
As one of the largest providers of corporate health care, the implementation of a blended learning system proved to be both challenging and complex. The aim of this session is to explore the lessons learnt through this process, highlighting successes, failures and the way forward in a corporate setting.
Derick Mitchell_Biobanking from the patient perspective.pdfipposi
IPPOSI CEO Derick Mitchell presented the patient perspective on biobanking at the 2023 WECAN Academy for Cancer Patient Advocates on July 2nd, 2023 in Frankfurt, Germany.
Mental Health - Leading the data sharing charge with a rights-based approachipposi
Frankie Prendergast's (Digital Health Applications Programme Manager in St Patrick's Mental Health Services) presentation on health information at the 2023 IPPOSI Conference.
Muiris O'Connor, Assistant Secretary of the Department of Health, presented key government updates on health information at the 2023 IPPOSI Conference Building a Data Sharing Health Sector in Ireland.
Clinical Workflow for Capture of Patient Registry Dataipposi
Clare Harney, Managing Director of HD Health, gave a lightning presentation on managing data for patient registries at the 2023 IPPOSI Conference on Building a Data Sharing Health Sector in Ireland.
EU Clinical Trials Regulation - IPPOSI perspectiveipposi
IPPOSI CEO, Dr Derick Mitchell delivered a presentation on the EU Clinical Trials Regulation from the patients' perspective at the 20th International Conference on Pharmaceutical Medicine, Athens, Greece.
Patient Centricity in Value-based healthcare, Sept 2022ipposi
IPPOSI CEO Derick Mitchell delivered a presentation as part of the RCSI Value Based Healthcare Webinar on Patient Centricity on Sept 18th, 2022.
The Future of Value Based Healthcare in Ireland webinar series is run by The RCSI Healthcare Outcomes Research Centre, Janssen Sciences Ireland UC and Novartis Ireland.
2022 World Day Brain Event - IPPOSI Presentationipposi
Laura Kavanagh, Research and Advocacy Manager in IPPOSI, gave a presentation on World Brain Day 2022 at an event hosted by the Neurological Alliance of Ireland.
In October 2020, IPPOSI published a membership engagement survey on its draft 4-year strategy. This slide deck captures the summary results of the survey.
IPPOSI CEO Derick Mitchell delivered a presentation on Dec 6th 2019 at the Digital health Conference, organised as part of the Royal College of Physicians, Ireland
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
2. Who We Are
• Patient Led Organisation
• CURE: Research – invested €17 million 85 projects
• SUPPORT: Counselling and Therapy
• EMPOWER: Advocacy, Education, Information
• Representing patients
• 224,000 people with severe vision loss in Ireland
• 5,000 people with rare retinal conditions
www.FightingBlindness.ie
5. www.FightingBlindness.ie
• But now we have hope.
• This announcement moves RhoNova™ further towards
clinical application and closer to the people who will
benefit from it.
• It’s is a prime example of the power of patient
involvement and how patient-led research can make a
real impact in the development of therapies.
• We are very proud in Fighting Blindness, and on behalf of
our members, to have played a part
in that.
Fighting Blindness – Genable – Spark
6. www.FightingBlindness.ie
……..Unlimited Vision
The team behind Genable – Prof Jane Farrar, Prof Peter
Humphries and Dr Paul Kenna – have spent over 30 years
investigating retinitis pigmentosa (RP) and Fighting Blindness,
its supporters and its members have been right beside them.